nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—TDO2—Tryptophan metabolism—ALDH1A2—prostate cancer	0.0251	0.082	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—AOX1—prostate cancer	0.02	0.0655	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP7B1—prostate cancer	0.0148	0.0483	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—ACHE—prostate cancer	0.0108	0.0353	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Conjugated Estrogens—prostate cancer	0.0105	1	CbGbCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP2C18—prostate cancer	0.00998	0.0326	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—HAO1—prostate cancer	0.00912	0.0298	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TH—prostate cancer	0.00884	0.0289	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00852	0.0279	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PSAT1—prostate cancer	0.00743	0.0243	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CSAD—prostate cancer	0.00743	0.0243	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—TST—prostate cancer	0.00743	0.0243	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—ADI1—prostate cancer	0.00743	0.0243	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00695	0.0227	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—GRHPR—prostate cancer	0.00691	0.0226	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CKMT2—prostate cancer	0.00691	0.0226	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP2E1—prostate cancer	0.00678	0.0222	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP3A4—prostate cancer	0.00654	0.0214	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—ITGB3—prostate cancer	0.00651	0.0213	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1B1—prostate cancer	0.00643	0.021	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP19A1—prostate cancer	0.00605	0.0198	CbGpPWpGaD
Nalidixic Acid—Pefloxacin—TOP2A—prostate cancer	0.00495	0.231	CrCbGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A1—prostate cancer	0.00487	0.0159	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—MTAP—prostate cancer	0.00479	0.0157	CbGpPWpGaD
Nalidixic Acid—Enoxacin—TOP2A—prostate cancer	0.00463	0.216	CrCbGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PHGDH—prostate cancer	0.00427	0.014	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—ARG2—prostate cancer	0.00427	0.014	CbGpPWpGaD
Nalidixic Acid—Lomefloxacin—TOP2A—prostate cancer	0.00351	0.164	CrCbGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—MDM2—prostate cancer	0.00301	0.00983	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00265	0.00866	CbGpPWpGaD
Nalidixic Acid—Norfloxacin—TOP2A—prostate cancer	0.00243	0.113	CrCbGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—SLC5A5—prostate cancer	0.00225	0.00736	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—NQO1—prostate cancer	0.00217	0.00711	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—TH—prostate cancer	0.00214	0.00701	CbGpPWpGaD
Nalidixic Acid—Norfloxacin—CYP3A5—prostate cancer	0.00192	0.0896	CrCbGaD
Nalidixic Acid—Norfloxacin—CYP2A6—prostate cancer	0.00186	0.0867	CrCbGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.00171	0.00558	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HAO1—prostate cancer	0.00167	0.00547	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00152	0.00498	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.00139	0.00455	CbGpPWpGaD
Nalidixic Acid—Diplopia—Capecitabine—prostate cancer	0.00138	0.00209	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Goserelin—prostate cancer	0.00138	0.00208	CcSEcCtD
Nalidixic Acid—Nausea—Cabazitaxel—prostate cancer	0.00137	0.00207	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.00137	0.00207	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—TST—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ADI1—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CSAD—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GRHL1—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PSAT1—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CBR1—prostate cancer	0.00136	0.00446	CbGpPWpGaD
Nalidixic Acid—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00136	0.00206	CcSEcCtD
Nalidixic Acid—Diarrhoea—Bicalutamide—prostate cancer	0.00135	0.00204	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Goserelin—prostate cancer	0.00135	0.00204	CcSEcCtD
Nalidixic Acid—Injury—Prednisone—prostate cancer	0.00134	0.00203	CcSEcCtD
Nalidixic Acid—Erythema—Estradiol—prostate cancer	0.00134	0.00202	CcSEcCtD
Nalidixic Acid—Urticaria—Ethinyl Estradiol—prostate cancer	0.00133	0.00201	CcSEcCtD
Nalidixic Acid—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00132	0.002	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.00131	0.00199	CcSEcCtD
Nalidixic Acid—Dizziness—Bicalutamide—prostate cancer	0.00131	0.00198	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A1—prostate cancer	0.0013	0.0607	CrCbGaD
Nalidixic Acid—Neuropathy peripheral—Etoposide—prostate cancer	0.0013	0.00196	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GRHPR—prostate cancer	0.00127	0.00415	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CKMT2—prostate cancer	0.00127	0.00415	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UGT2B15—prostate cancer	0.00127	0.00415	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UGT2B17—prostate cancer	0.00127	0.00415	CbGpPWpGaD
Nalidixic Acid—Vomiting—Bicalutamide—prostate cancer	0.00126	0.0019	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00125	0.00189	CcSEcCtD
Nalidixic Acid—Rash—Bicalutamide—prostate cancer	0.00125	0.00188	CcSEcCtD
Nalidixic Acid—Dermatitis—Bicalutamide—prostate cancer	0.00125	0.00188	CcSEcCtD
Nalidixic Acid—Erythema—Mitoxantrone—prostate cancer	0.00125	0.00188	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.00124	0.00188	CcSEcCtD
Nalidixic Acid—Headache—Bicalutamide—prostate cancer	0.00124	0.00187	CcSEcCtD
Nalidixic Acid—Paraesthesia—Goserelin—prostate cancer	0.00124	0.00187	CcSEcCtD
Nalidixic Acid—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00122	0.00185	CcSEcCtD
Nalidixic Acid—Somnolence—Goserelin—prostate cancer	0.00122	0.00185	CcSEcCtD
Nalidixic Acid—Angioedema—Estradiol—prostate cancer	0.00122	0.00185	CcSEcCtD
Nalidixic Acid—Somnolence—Conjugated Estrogens—prostate cancer	0.00121	0.00183	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Prednisone—prostate cancer	0.0012	0.00182	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.0012	0.00394	CbGpPWpGaD
Nalidixic Acid—Vertigo—Estradiol—prostate cancer	0.0012	0.00181	CcSEcCtD
Nalidixic Acid—Asthenia—Ethinyl Estradiol—prostate cancer	0.0012	0.00181	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MBTPS1—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SULT2B1—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PGAM2—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AOX1—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM3—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—RFK—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NAGLU—prostate cancer	0.00119	0.0039	CbGpPWpGaD
Nalidixic Acid—Pruritus—Ethinyl Estradiol—prostate cancer	0.00118	0.00179	CcSEcCtD
Nalidixic Acid—Nausea—Bicalutamide—prostate cancer	0.00118	0.00178	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00114	0.00173	CcSEcCtD
Nalidixic Acid—Arthralgia—Estradiol—prostate cancer	0.00114	0.00172	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP3A43—prostate cancer	0.00113	0.0037	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AMACR—prostate cancer	0.00113	0.0037	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NAT1—prostate cancer	0.00113	0.0037	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SRD5A2—prostate cancer	0.00113	0.0037	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—DEGS1—prostate cancer	0.00113	0.0037	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Goserelin—prostate cancer	0.00113	0.0017	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—prostate cancer	0.00113	0.0017	CcSEcCtD
Nalidixic Acid—Leukopenia—Mitoxantrone—prostate cancer	0.00112	0.00168	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.00112	0.00168	CcSEcCtD
Nalidixic Acid—Dizziness—Ethinyl Estradiol—prostate cancer	0.00111	0.00167	CcSEcCtD
Nalidixic Acid—Urticaria—Goserelin—prostate cancer	0.00109	0.00165	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.00109	0.00165	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Capecitabine—prostate cancer	0.00109	0.00165	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Estradiol—prostate cancer	0.00109	0.00165	CcSEcCtD
Nalidixic Acid—Abdominal pain—Goserelin—prostate cancer	0.00109	0.00164	CcSEcCtD
Nalidixic Acid—Urticaria—Conjugated Estrogens—prostate cancer	0.00108	0.00164	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Docetaxel—prostate cancer	0.00108	0.00163	CcSEcCtD
Nalidixic Acid—Convulsion—Mitoxantrone—prostate cancer	0.00108	0.00163	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD17B1—prostate cancer	0.00108	0.00353	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00108	0.00163	CcSEcCtD
Nalidixic Acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.00106	0.00161	CcSEcCtD
Nalidixic Acid—Arthralgia—Mitoxantrone—prostate cancer	0.00106	0.0016	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.00106	0.0016	CcSEcCtD
Nalidixic Acid—Rash—Ethinyl Estradiol—prostate cancer	0.00105	0.00159	CcSEcCtD
Nalidixic Acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00105	0.00159	CcSEcCtD
Nalidixic Acid—Headache—Ethinyl Estradiol—prostate cancer	0.00105	0.00158	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Capecitabine—prostate cancer	0.00105	0.00158	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00102	0.00154	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—prostate cancer	0.00101	0.00152	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000997	0.00151	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000996	0.0015	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000994	0.0015	CcSEcCtD
Nalidixic Acid—Nausea—Ethinyl Estradiol—prostate cancer	0.000994	0.0015	CcSEcCtD
Nalidixic Acid—Asthenia—Goserelin—prostate cancer	0.000988	0.00149	CcSEcCtD
Nalidixic Acid—Paraesthesia—Estradiol—prostate cancer	0.00098	0.00148	CcSEcCtD
Nalidixic Acid—Asthenia—Conjugated Estrogens—prostate cancer	0.000978	0.00148	CcSEcCtD
Nalidixic Acid—Pruritus—Goserelin—prostate cancer	0.000974	0.00147	CcSEcCtD
Nalidixic Acid—Somnolence—Estradiol—prostate cancer	0.00097	0.00147	CcSEcCtD
Nalidixic Acid—Pruritus—Conjugated Estrogens—prostate cancer	0.000965	0.00146	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—prostate cancer	0.000965	0.00146	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—B4GALT4—prostate cancer	0.000962	0.00314	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HPGD—prostate cancer	0.000962	0.00314	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000957	0.00313	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000957	0.00313	CbGpPWpGaD
Nalidixic Acid—Visual impairment—Docetaxel—prostate cancer	0.000953	0.00144	CcSEcCtD
Nalidixic Acid—Diarrhoea—Goserelin—prostate cancer	0.000942	0.00142	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Docetaxel—prostate cancer	0.000935	0.00141	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—prostate cancer	0.000934	0.00141	CcSEcCtD
Nalidixic Acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000933	0.00141	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisone—prostate cancer	0.000932	0.00141	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—prostate cancer	0.000931	0.00141	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—prostate cancer	0.000928	0.0014	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000926	0.0014	CcSEcCtD
Nalidixic Acid—Visual impairment—Capecitabine—prostate cancer	0.000923	0.00139	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000922	0.00139	CcSEcCtD
Nalidixic Acid—Paraesthesia—Mitoxantrone—prostate cancer	0.000913	0.00138	CcSEcCtD
Nalidixic Acid—Dizziness—Goserelin—prostate cancer	0.00091	0.00137	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Capecitabine—prostate cancer	0.000906	0.00137	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—TNFRSF21—prostate cancer	0.000904	0.00296	CbGpPWpGaD
Nalidixic Acid—Somnolence—Mitoxantrone—prostate cancer	0.000904	0.00137	CcSEcCtD
Nalidixic Acid—Dizziness—Conjugated Estrogens—prostate cancer	0.000902	0.00136	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—prostate cancer	0.000898	0.00136	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—prostate cancer	0.000893	0.00135	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Estradiol—prostate cancer	0.000892	0.00135	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MTAP—prostate cancer	0.00088	0.00288	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP7B1—prostate cancer	0.00088	0.00288	CbGpPWpGaD
Nalidixic Acid—Vomiting—Goserelin—prostate cancer	0.000875	0.00132	CcSEcCtD
Nalidixic Acid—Rash—Goserelin—prostate cancer	0.000868	0.00131	CcSEcCtD
Nalidixic Acid—Dermatitis—Goserelin—prostate cancer	0.000867	0.00131	CcSEcCtD
Nalidixic Acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000867	0.00131	CcSEcCtD
Nalidixic Acid—Urticaria—Estradiol—prostate cancer	0.000867	0.00131	CcSEcCtD
Nalidixic Acid—Abdominal pain—Estradiol—prostate cancer	0.000863	0.0013	CcSEcCtD
Nalidixic Acid—Headache—Goserelin—prostate cancer	0.000862	0.0013	CcSEcCtD
Nalidixic Acid—Erythema—Docetaxel—prostate cancer	0.000861	0.0013	CcSEcCtD
Nalidixic Acid—Rash—Conjugated Estrogens—prostate cancer	0.00086	0.0013	CcSEcCtD
Nalidixic Acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000859	0.0013	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SULT1E1—prostate cancer	0.000857	0.0028	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SRD5A1—prostate cancer	0.000857	0.0028	CbGpPWpGaD
Nalidixic Acid—Headache—Conjugated Estrogens—prostate cancer	0.000854	0.00129	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—prostate cancer	0.000846	0.00128	CcSEcCtD
Nalidixic Acid—Erythema—Capecitabine—prostate cancer	0.000834	0.00126	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000832	0.00126	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP3A4—prostate cancer	0.000831	0.0388	CrCbGaD
Nalidixic Acid—Thrombocytopenia—Etoposide—prostate cancer	0.000828	0.00125	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—prostate cancer	0.000826	0.00125	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD17B3—prostate cancer	0.000818	0.00267	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ACSL4—prostate cancer	0.000818	0.00267	CbGpPWpGaD
Nalidixic Acid—Nausea—Goserelin—prostate cancer	0.000818	0.00123	CcSEcCtD
Nalidixic Acid—Nausea—Conjugated Estrogens—prostate cancer	0.00081	0.00122	CcSEcCtD
Nalidixic Acid—Urticaria—Mitoxantrone—prostate cancer	0.000808	0.00122	CcSEcCtD
Nalidixic Acid—Abdominal pain—Mitoxantrone—prostate cancer	0.000804	0.00121	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ARG2—prostate cancer	0.000784	0.00256	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PHGDH—prostate cancer	0.000784	0.00256	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UMPS—prostate cancer	0.000784	0.00256	CbGpPWpGaD
Nalidixic Acid—Asthenia—Estradiol—prostate cancer	0.000783	0.00118	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000776	0.00254	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000774	0.00253	CbGpPWpGaD
Nalidixic Acid—Pruritus—Estradiol—prostate cancer	0.000772	0.00117	CcSEcCtD
Nalidixic Acid—Leukopenia—Docetaxel—prostate cancer	0.000771	0.00116	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—LDHB—prostate cancer	0.000769	0.00251	CbGpPWpGaD
Nalidixic Acid—Eosinophilia—Doxorubicin—prostate cancer	0.000764	0.00115	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—prostate cancer	0.000761	0.00115	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—prostate cancer	0.00076	0.00115	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP3A5—prostate cancer	0.000755	0.00247	CbGpPWpGaD
Nalidixic Acid—Somnolence—Etoposide—prostate cancer	0.000752	0.00114	CcSEcCtD
Nalidixic Acid—Vertigo—Capecitabine—prostate cancer	0.000749	0.00113	CcSEcCtD
Nalidixic Acid—Diarrhoea—Estradiol—prostate cancer	0.000747	0.00113	CcSEcCtD
Nalidixic Acid—Leukopenia—Capecitabine—prostate cancer	0.000746	0.00113	CcSEcCtD
Nalidixic Acid—Convulsion—Docetaxel—prostate cancer	0.000746	0.00113	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—prostate cancer	0.000743	0.00112	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—prostate cancer	0.000743	0.00112	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000737	0.00111	CcSEcCtD
Nalidixic Acid—Arthralgia—Docetaxel—prostate cancer	0.000733	0.00111	CcSEcCtD
Nalidixic Acid—Asthenia—Mitoxantrone—prostate cancer	0.00073	0.0011	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PDHA1—prostate cancer	0.000729	0.00238	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTA3—prostate cancer	0.000729	0.00238	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UCP3—prostate cancer	0.000729	0.00238	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—TCN2—prostate cancer	0.000729	0.00238	CbGpPWpGaD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—prostate cancer	0.000729	0.0011	CcSEcCtD
Nalidixic Acid—Dizziness—Estradiol—prostate cancer	0.000722	0.00109	CcSEcCtD
Nalidixic Acid—Arthralgia—Capecitabine—prostate cancer	0.00071	0.00107	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000704	0.00106	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Docetaxel—prostate cancer	0.000703	0.00106	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mitoxantrone—prostate cancer	0.000696	0.00105	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD3B1—prostate cancer	0.000695	0.00227	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC22A3—prostate cancer	0.000695	0.00227	CbGpPWpGaD
Nalidixic Acid—Vomiting—Estradiol—prostate cancer	0.000694	0.00105	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—prostate cancer	0.000692	0.00104	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Docetaxel—prostate cancer	0.000688	0.00104	CcSEcCtD
Nalidixic Acid—Rash—Estradiol—prostate cancer	0.000688	0.00104	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—prostate cancer	0.000688	0.00104	CcSEcCtD
Nalidixic Acid—Dermatitis—Estradiol—prostate cancer	0.000687	0.00104	CcSEcCtD
Nalidixic Acid—Headache—Estradiol—prostate cancer	0.000684	0.00103	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000682	0.00103	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—prostate cancer	0.000679	0.00102	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000674	0.00102	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—prostate cancer	0.000672	0.00101	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—prostate cancer	0.000669	0.00101	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—prostate cancer	0.000667	0.00101	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA4—prostate cancer	0.000667	0.00218	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—TBXAS1—prostate cancer	0.000667	0.00218	CbGpPWpGaD
Nalidixic Acid—Thrombocytopenia—Capecitabine—prostate cancer	0.000666	0.00101	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA2—prostate cancer	0.00065	0.00212	CbGpPWpGaD
Nalidixic Acid—Nausea—Estradiol—prostate cancer	0.000648	0.000979	CcSEcCtD
Nalidixic Acid—Vomiting—Mitoxantrone—prostate cancer	0.000647	0.000976	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—prostate cancer	0.000644	0.000972	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—prostate cancer	0.000643	0.000971	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ABCG5—prostate cancer	0.000642	0.0021	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SULT1A1—prostate cancer	0.000642	0.0021	CbGpPWpGaD
Nalidixic Acid—Rash—Mitoxantrone—prostate cancer	0.000641	0.000968	CcSEcCtD
Nalidixic Acid—Dermatitis—Mitoxantrone—prostate cancer	0.000641	0.000967	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.00064	0.000967	CcSEcCtD
Nalidixic Acid—Headache—Mitoxantrone—prostate cancer	0.000637	0.000962	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000633	0.00207	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Prednisone—prostate cancer	0.000632	0.000955	CcSEcCtD
Nalidixic Acid—Paraesthesia—Docetaxel—prostate cancer	0.000631	0.000953	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—prostate cancer	0.000631	0.000953	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA1—prostate cancer	0.000627	0.00205	CbGpPWpGaD
Nalidixic Acid—Somnolence—Docetaxel—prostate cancer	0.000625	0.000944	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00062	0.000936	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD3B2—prostate cancer	0.00062	0.00203	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NAT2—prostate cancer	0.00062	0.00203	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTO1—prostate cancer	0.00062	0.00203	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000612	0.002	CbGpPWpGaD
Nalidixic Acid—Paraesthesia—Capecitabine—prostate cancer	0.000611	0.000923	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—prostate cancer	0.000607	0.000916	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—prostate cancer	0.000606	0.000915	CcSEcCtD
Nalidixic Acid—Nausea—Mitoxantrone—prostate cancer	0.000604	0.000912	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—prostate cancer	0.000598	0.000904	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—prostate cancer	0.000595	0.000899	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—LRP2—prostate cancer	0.000594	0.00194	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PLCB2—prostate cancer	0.000594	0.00194	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2C18—prostate cancer	0.000594	0.00194	CbGpPWpGaD
Nalidixic Acid—Erythema multiforme—Doxorubicin—prostate cancer	0.000584	0.000882	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—P4HB—prostate cancer	0.000583	0.00191	CbGpPWpGaD
Nalidixic Acid—Erythema—Epirubicin—prostate cancer	0.000581	0.000877	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—prostate cancer	0.000579	0.000874	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Docetaxel—prostate cancer	0.000575	0.000868	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC22A1—prostate cancer	0.000567	0.00185	CbGpPWpGaD
Nalidixic Acid—Dizziness—Etoposide—prostate cancer	0.000559	0.000845	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Capecitabine—prostate cancer	0.000557	0.00084	CcSEcCtD
Nalidixic Acid—Abdominal pain—Docetaxel—prostate cancer	0.000556	0.000839	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SULT2A1—prostate cancer	0.000552	0.00181	CbGpPWpGaD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000552	0.000834	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—prostate cancer	0.000544	0.000822	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MED12—prostate cancer	0.000543	0.00178	CbGpPWpGaD
Nalidixic Acid—Urticaria—Capecitabine—prostate cancer	0.000541	0.000816	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GNG5—prostate cancer	0.000539	0.00176	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Capecitabine—prostate cancer	0.000538	0.000812	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—prostate cancer	0.000538	0.000812	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—prostate cancer	0.000538	0.000812	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—prostate cancer	0.000533	0.000805	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—prostate cancer	0.000533	0.000805	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—prostate cancer	0.00053	0.0008	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—prostate cancer	0.000522	0.000788	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—prostate cancer	0.00052	0.000785	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NCOA3—prostate cancer	0.000519	0.0017	CbGpPWpGaD
Nalidixic Acid—Asthenia—Docetaxel—prostate cancer	0.000504	0.000762	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—prostate cancer	0.000503	0.00076	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—prostate cancer	0.000502	0.000759	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000499	0.00163	CbGpPWpGaD
Nalidixic Acid—Pruritus—Docetaxel—prostate cancer	0.000497	0.000751	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—prostate cancer	0.000496	0.000749	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HPGDS—prostate cancer	0.000495	0.00162	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Epirubicin—prostate cancer	0.000495	0.000747	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP2C19—prostate cancer	0.000492	0.00161	CbGpPWpGaD
Nalidixic Acid—Asthenia—Capecitabine—prostate cancer	0.000488	0.000737	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000486	0.00159	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000486	0.00159	CbGpPWpGaD
Nalidixic Acid—Vertigo—Doxorubicin—prostate cancer	0.000483	0.000729	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisone—prostate cancer	0.000482	0.000727	CcSEcCtD
Nalidixic Acid—Pruritus—Capecitabine—prostate cancer	0.000482	0.000727	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—prostate cancer	0.000481	0.000727	CcSEcCtD
Nalidixic Acid—Diarrhoea—Docetaxel—prostate cancer	0.000481	0.000726	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ACHE—prostate cancer	0.000481	0.00157	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—prostate cancer	0.000481	0.00157	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Prednisone—prostate cancer	0.000479	0.000724	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP2A6—prostate cancer	0.000475	0.00155	CbGpPWpGaD
Nalidixic Acid—Anaphylactic shock—Epirubicin—prostate cancer	0.000474	0.000716	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—prostate cancer	0.000466	0.000703	CcSEcCtD
Nalidixic Acid—Diarrhoea—Capecitabine—prostate cancer	0.000466	0.000703	CcSEcCtD
Nalidixic Acid—Dizziness—Docetaxel—prostate cancer	0.000465	0.000702	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—prostate cancer	0.000464	0.000701	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—AKR1C3—prostate cancer	0.000462	0.00151	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000461	0.00151	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PRKACB—prostate cancer	0.00046	0.0015	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Doxorubicin—prostate cancer	0.000458	0.000691	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP17A1—prostate cancer	0.000455	0.00149	CbGpPWpGaD
Nalidixic Acid—Dizziness—Capecitabine—prostate cancer	0.00045	0.00068	CcSEcCtD
Nalidixic Acid—Vomiting—Docetaxel—prostate cancer	0.000447	0.000675	CcSEcCtD
Nalidixic Acid—Rash—Docetaxel—prostate cancer	0.000443	0.000669	CcSEcCtD
Nalidixic Acid—Dermatitis—Docetaxel—prostate cancer	0.000443	0.000669	CcSEcCtD
Nalidixic Acid—Headache—Docetaxel—prostate cancer	0.00044	0.000665	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—prostate cancer	0.000439	0.000662	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—prostate cancer	0.000435	0.000657	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NCOA2—prostate cancer	0.000433	0.00142	CbGpPWpGaD
Nalidixic Acid—Vomiting—Capecitabine—prostate cancer	0.000433	0.000653	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000432	0.000652	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—prostate cancer	0.00043	0.000649	CcSEcCtD
Nalidixic Acid—Rash—Capecitabine—prostate cancer	0.000429	0.000648	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—prostate cancer	0.000429	0.000648	CcSEcCtD
Nalidixic Acid—Dermatitis—Capecitabine—prostate cancer	0.000429	0.000647	CcSEcCtD
Nalidixic Acid—Headache—Capecitabine—prostate cancer	0.000426	0.000644	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—prostate cancer	0.000426	0.000643	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—prostate cancer	0.000422	0.000636	CcSEcCtD
Nalidixic Acid—Nausea—Docetaxel—prostate cancer	0.000418	0.00063	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—prostate cancer	0.000415	0.000626	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC5A5—prostate cancer	0.000413	0.00135	CbGpPWpGaD
Nalidixic Acid—Nausea—Capecitabine—prostate cancer	0.000404	0.00061	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP2E1—prostate cancer	0.000404	0.00132	CbGpPWpGaD
Nalidixic Acid—Dizziness—Prednisone—prostate cancer	0.000401	0.000605	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.0004	0.000604	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NQO1—prostate cancer	0.000399	0.00131	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000394	0.00129	CbGpPWpGaD
Nalidixic Acid—Paraesthesia—Doxorubicin—prostate cancer	0.000394	0.000595	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—TH—prostate cancer	0.000394	0.00129	CbGpPWpGaD
Nalidixic Acid—Somnolence—Doxorubicin—prostate cancer	0.00039	0.000589	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP3A4—prostate cancer	0.000389	0.00127	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—prostate cancer	0.000388	0.000585	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—prostate cancer	0.000385	0.000582	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP1B1—prostate cancer	0.000383	0.00125	CbGpPWpGaD
Nalidixic Acid—Rash—Prednisone—prostate cancer	0.000382	0.000577	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—prostate cancer	0.000382	0.000577	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—prostate cancer	0.00038	0.000573	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—prostate cancer	0.000377	0.000569	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—prostate cancer	0.000375	0.000566	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GGT1—prostate cancer	0.000371	0.00121	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NCOA1—prostate cancer	0.000365	0.00119	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000364	0.00119	CbGpPWpGaD
Nalidixic Acid—Nausea—Prednisone—prostate cancer	0.00036	0.000544	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP19A1—prostate cancer	0.00036	0.00118	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000359	0.000542	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—prostate cancer	0.000349	0.000526	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—RXRA—prostate cancer	0.000347	0.00114	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Doxorubicin—prostate cancer	0.000347	0.000524	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—prostate cancer	0.00034	0.000514	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—prostate cancer	0.000335	0.000507	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—COMT—prostate cancer	0.000335	0.00109	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTP1—prostate cancer	0.000333	0.00109	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ITPR1—prostate cancer	0.000328	0.00107	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Epirubicin—prostate cancer	0.000324	0.00049	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000321	0.00105	CbGpPWpGaD
Nalidixic Acid—Asthenia—Doxorubicin—prostate cancer	0.000315	0.000475	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—prostate cancer	0.000314	0.000473	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—prostate cancer	0.00031	0.000469	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—TYMS—prostate cancer	0.00031	0.00101	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—prostate cancer	0.000306	0.001	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000306	0.001	CbGpPWpGaD
Nalidixic Acid—Vomiting—Epirubicin—prostate cancer	0.000301	0.000455	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—LPL—prostate cancer	0.0003	0.000982	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Doxorubicin—prostate cancer	0.0003	0.000453	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—prostate cancer	0.000299	0.000451	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—prostate cancer	0.000299	0.000451	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—prostate cancer	0.000297	0.000449	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP1A1—prostate cancer	0.00029	0.000949	CbGpPWpGaD
Nalidixic Acid—Dizziness—Doxorubicin—prostate cancer	0.00029	0.000438	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ERCC2—prostate cancer	0.000288	0.000941	CbGpPWpGaD
Nalidixic Acid—Nausea—Epirubicin—prostate cancer	0.000282	0.000425	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—prostate cancer	0.000279	0.000421	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—prostate cancer	0.000277	0.000418	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—prostate cancer	0.000276	0.000417	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—prostate cancer	0.000275	0.000415	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MTHFR—prostate cancer	0.000271	0.000884	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPARA—prostate cancer	0.000265	0.000868	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000261	0.000852	CbGpPWpGaD
Nalidixic Acid—Nausea—Doxorubicin—prostate cancer	0.000261	0.000393	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CAV1—prostate cancer	0.00025	0.000816	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000246	0.000804	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000235	0.000767	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CG—prostate cancer	0.000227	0.000743	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—INS—prostate cancer	0.000215	0.000703	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CREBBP—prostate cancer	0.000211	0.000689	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000207	0.000677	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CD—prostate cancer	0.0002	0.000653	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000197	0.000644	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NOS3—prostate cancer	0.000189	0.000617	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CB—prostate cancer	0.000174	0.000569	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—prostate cancer	0.000173	0.000564	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000151	0.000492	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTEN—prostate cancer	0.00015	0.000492	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—EP300—prostate cancer	0.000144	0.000469	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.00012	0.000391	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—prostate cancer	0.000106	0.000347	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AKT1—prostate cancer	8.67e-05	0.000284	CbGpPWpGaD
